Ferric carboxymaltose Archives - Medical Conferences

Intravenous iron deficiency treatment improves exercise capacity in patients with HFpEF

Presented By

Prof. Stephan von Haehling, University Medical Centre of Göttingen, Germany

Trial

Phase 2, FAIR-HFpEF

Conference

HFA 2024

Type

Peer-reviewed article

16 July 2024 16:33

Meta-analysis: Does FCM improve clinical outcomes in HF?

Presented By

Prof. Piotr Ponikowski, Medical University Wroclaw, Poland

Trial

CONFIRM-HF; AFFIRM-AHF; HEART-FID

Conference

ESC 2023

Type

Peer-reviewed article

30 October 2023 16:06

HEART-FID: Is intravenous ferric carboxymaltose helpful in HFrEF with iron deficiency?

Presented By

Dr Robert Mentz, Duke University, USA

Trial

Phase 3, HEART-FID

Conference

ESC 2023

Type

Peer-reviewed article

30 October 2023 16:05

2021 ESC Guidelines on Heart Failure

Presented By

Prof. Carolyn Lam, Duke-NUS Medical School, Singapore

Conference

ESC 2021

Type

Peer-reviewed article

26 October 2021 12:34

Iron substitution improves LVEF in intensively treated CRT patients with iron deficiency

Presented By

Dr Pieter Martens, Hospital Oost-Limburg, Belgium

Trial

Phase 4, IRON-CRT

Conference

HFA 2021

Type

Peer-reviewed article

19 August 2021 16:10

Iron substitution in iron-deficient HF patients is highly cost-effective

Presented By

Prof. Phil McEwan, Swansea University, UK

Trial

AFFIRM-AHF

Conference

HFA 2021

Type

Peer-reviewed article

19 August 2021 15:59

IV iron reduces HF hospitalisation

Presented By

Prof. Piotr Ponikowski, Wroclaw Medical University, Poland

Trial

AFFIRM-AHF

Conference

AHA 2020

Type

Peer-reviewed article

18 February 2021 10:22